Carnegie Investment Counsel Buys 1,193 Shares of Bristol-Myers Squibb (NYSE:BMY)
Carnegie Investment Counsel raised its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 3.7% in the 4th quarter, Holdings Channel.com reports. The fund owned...
Ritholtz Wealth Management Lowers Position in Johnson & Johnson (NYSE:JNJ)
Ritholtz Wealth Management lowered its position in Johnson & Johnson (NYSE:JNJ – Free Report) by 8.5% in the fourth quarter, according to the company in...
Carnegie Investment Counsel Purchases 1,429 Shares of iShares Russell 2000 Growth ETF (NYSEARCA:IWO)
Carnegie Investment Counsel increased its position in iShares Russell 2000 Growth ETF (NYSEARCA:IWO – Free Report) by 15.6% in the 4th quarter, according to the...
Ritholtz Wealth Management Trims Stake in Lowe’s Companies, Inc. (NYSE:LOW)
Ritholtz Wealth Management lessened its holdings in Lowe’s Companies, Inc. (NYSE:LOW – Free Report) by 0.5% during the fourth quarter, HoldingsChannel reports. The institutional investor...
Needham & Company LLC Reiterates “Hold” Rating for Revance Therapeutics (NASDAQ:RVNC)
Needham & Company LLC reiterated their hold rating on shares of Revance Therapeutics (NASDAQ:RVNC – Free Report) in a research report report published on Friday...
Victory Capital (NASDAQ:VCTR) Given New $70.00 Price Target at Barclays
Victory Capital (NASDAQ:VCTR – Free Report) had its price objective upped by Barclays from $69.00 to $70.00 in a report published on Friday,Benzinga reports. They...